Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo R Fitzpatrick

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Inflammopharmacology|April 10, 2014
The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in miceLeo R Fitzpatrick, Elizabeth Stonesifer, Jeffrey S Small, et al.
Inflammopharmacology|September 25, 2019
VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel diseaseLeo R Fitzpatrick, Jeff Small, Robert O'Connell, et al.
Gut Pathogens|October 22, 2011
Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in miceLeo R Fitzpatrick, Jeffrey S Small, Wallace H Greene, et al.
Inflammopharmacology|February 13, 2010
Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's diseaseLynn W Maines, Leo R Fitzpatrick, Cecelia L Green, et al.
Diseases of the Colon and Rectum|December 13, 2006
Enhanced intestinal expression of the proteasome subunit low molecular mass polypeptide 2 in patients with inflammatory bowel diseaseLeo R Fitzpatrick, Jeffrey S Small, Lisa S Poritz, et al.
International Journal of Nephrology and Renovascular Disease|November 24, 2022
The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in MiceLynn W Maines, Cecelia L Green, Staci N Keller, et al.
Gut Pathogens|October 24, 2012
Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in miceLeo R Fitzpatrick, Jeffrey S Small, Wallace H Greene, et al.
The British Journal of Nutrition|February 19, 2008
In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitisLeo R Fitzpatrick, Jeffrey Small, Robert A Hoerr, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 27, 2007
Effects of the probiotic formulation VSL#3 on colitis in weanling ratsLeo R Fitzpatrick, Kristy L Hertzog, Angela L Quatse, et al.
Comparative Medicine|January 24, 2020
Role of the δ-Opioid Receptor in 2 Murine Models of ColitisTia R Bobo, Leo R Fitzpatrick, Tiffany L Whitcomb, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Inflammopharmacology|April 10, 2014
The synthetic triterpenoid (CDDO-Im) inhibits STAT3, as well as IL-17, and improves DSS-induced colitis in miceLeo R Fitzpatrick, Elizabeth Stonesifer, Jeffrey S Small, et al.
Inflammopharmacology|September 25, 2019
VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel diseaseLeo R Fitzpatrick, Jeff Small, Robert O'Connell, et al.
Gut Pathogens|October 22, 2011
Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in miceLeo R Fitzpatrick, Jeffrey S Small, Wallace H Greene, et al.
Inflammopharmacology|February 13, 2010
Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's diseaseLynn W Maines, Leo R Fitzpatrick, Cecelia L Green, et al.
Diseases of the Colon and Rectum|December 13, 2006
Enhanced intestinal expression of the proteasome subunit low molecular mass polypeptide 2 in patients with inflammatory bowel diseaseLeo R Fitzpatrick, Jeffrey S Small, Lisa S Poritz, et al.
International Journal of Nephrology and Renovascular Disease|November 24, 2022
The Sphingosine Kinase 2 Inhibitor Opaganib Protects Against Acute Kidney Injury in MiceLynn W Maines, Cecelia L Green, Staci N Keller, et al.
Gut Pathogens|October 24, 2012
Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in miceLeo R Fitzpatrick, Jeffrey S Small, Wallace H Greene, et al.
The British Journal of Nutrition|February 19, 2008
In vitro and in vivo effects of the probiotic Escherichia coli strain M-17: immunomodulation and attenuation of murine colitisLeo R Fitzpatrick, Jeffrey Small, Robert A Hoerr, et al.
Journal of Pediatric Gastroenterology and Nutrition|April 27, 2007
Effects of the probiotic formulation VSL#3 on colitis in weanling ratsLeo R Fitzpatrick, Kristy L Hertzog, Angela L Quatse, et al.
Comparative Medicine|January 24, 2020
Role of the δ-Opioid Receptor in 2 Murine Models of ColitisTia R Bobo, Leo R Fitzpatrick, Tiffany L Whitcomb, et al.
Pageof 3